We're taking a closer look at Humana today, as the chatter surrounding the stock has increased notably in the last few weeks. Today, its shares moved -4.26% compared to -0.35% for the S&P 500. Increased investor interest and volatility surrounding the stock are not reason enough to buy in -- you should first perform your own due diligence. Here are some figures that can get you started:
-
Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.
-
Humana has moved 15.5% over the last year compared to -14.12% for the S&P 500 -- a difference of 29.62%
-
HUM has an average analyst rating of buy and is -19.18% away from its mean target price of $600.52 per share
-
Its trailing 12 month earnings per share (EPS) is $22.56
-
Humana has a trailing 12 month Price to Earnings (P/E) ratio of 21.51 while the S&P 500 average is 15.97
-
Its forward earnings per share (EPS) is $31.94 and its forward P/E ratio is 15.2
-
HUM has a Price to Earnings Growth (PEG) ratio of 1.283, which shows the company is fairly valued compared to its earnings.
-
The company has a Price to Book (P/B) ratio of 4.155 in contrast to the S&P 500's average ratio of 2.95
-
Humana is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
-
Humana has on average reported free cash flows of $3,039,400,000.00 over the last four years, during which time they have grown by an an average of 76.17%